For instance in hepatocellular carcinoma (HCC), an overexpression of glypican-3 increases the migratory ability and invasive capacity of cancer cells by reducing cell adhesion to fibronectin (Kwack et al. 2006) whereas it plays an inhibitory role in breast cancer. This evidence concerns the gene FN1 and breast carcinoma.